<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2025cv00523/88947</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2025cv00523/88947/feed" rel="self" type="application/rss+xml" />
        <pubDate>Thu, 04 Jun 2026 16:50:46 -0700</pubDate>
        <lastBuildDate>Thu, 04 Jun 2026 16:50:46 -0700</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al - Docket Entries - Showing 1 through 23</description>
                                    <item>
        <title>
                            <![CDATA[Document 23]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED CONSENT JUDGMENT by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987617</guid>
                <pubDate>
            Fri, 24 Oct 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 22]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #21 STIPULATION TO EXTEND TIME for Defendants Biocon Limited, Biocon Pharma, Inc. and Biocon Pharma Limited's initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and to produce an up to date version of Biocon's ANDA No. 220117 and any related FDA correspondence to September 29, 2025, filed by Biocon Limited, Biocon Pharma, Inc., Biocon Pharma Limited. Signed by Judge Colm F. Connolly on 9/24/2025. (kmd)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987618</guid>
                <pubDate>
            Wed, 24 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 21]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Defendants Biocon Limited, Biocon Pharma, Inc. and Biocon Pharma Limited's initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and to produce an up to date version of Biocon's ANDA No. 220117 and any related FDA correspondence to September 29, 2025 - filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Taylor, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987619</guid>
                <pubDate>
            Fri, 19 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 20]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #19 STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order to October 9, 2025, filed by Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 9/18/2025. (kmd)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987620</guid>
                <pubDate>
            Thu, 18 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 19]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for the parties to submit a proposed Protective Order to October 9, 2025 - filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987621</guid>
                <pubDate>
            Thu, 18 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 18]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #17 STIPULATION TO EXTEND TIME for Biocon Limited, Biocon Pharma, Inc. and Biocon Pharma Limited's Initial Disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) to September 17, 2025, filed by Biocon Limited, Biocon Pharma, Inc., Biocon Pharma Limited. Signed by Judge Colm F. Connolly on 9/12/2025. (kmd)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987622</guid>
                <pubDate>
            Fri, 12 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 17]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME for Biocon Limited, Biocon Pharma, Inc. and Biocon Pharma Limited's Initial Disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) to September 17, 2025 - filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Taylor, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987623</guid>
                <pubDate>
            Thu, 11 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 16]]>
                    </title>
                <description>
            <![CDATA[
                NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Plaintiffs' Preliminary Disclosure of Asserted Claims filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987624</guid>
                <pubDate>
            Wed, 10 Sep 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 15]]>
                    </title>
                <description>
            <![CDATA[
                SCHEDULING ORDER: Joinder of Parties due by 9/14/2026. Amended Pleadings due by 9/14/2026. Fact Discovery completed by 9/21/2026. Expert Discovery due by 2/10/2027. Joint Claim Construction Brief due by 4/22/2026. A Markman Hearing is set for 6/18/2026 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 3/22/2027. A Final Pretrial Conference is set for 4/12/2027 at 02:00 PM in Courtroom 4B before Judge Colm F. Connolly. A 5-day Bench Trial is set to begin 4/19/2027 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 8/19/2025. (mws)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987626</guid>
                <pubDate>
            Tue, 19 Aug 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Remark: The August 20, 2025 Scheduling Conference is cancelled per the filing and entry of a scheduling order with no areas of dispute. (mws)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987625</guid>
                <pubDate>
            Tue, 19 Aug 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 14]]>
                    </title>
                <description>
            <![CDATA[
                PROPOSED ORDER -- Scheduling Order -- re #13 Order Setting Scheduling Conference, by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: #1 Letter to The Honorable Colm F. Connolly)(Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987627</guid>
                <pubDate>
            Mon, 18 Aug 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 13]]>
                    </title>
                <description>
            <![CDATA[
                Order Setting Telephonic Scheduling Conference: A Telephonic Scheduling Conference is set for 8/20/2025 at 03:00 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 7/30/2025. (mws)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987628</guid>
                <pubDate>
            Wed, 30 Jul 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc.. (Belgam, Neal)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987629</guid>
                <pubDate>
            Mon, 28 Jul 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint, filed by Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc..(Taylor, Daniel)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_30987630</guid>
                <pubDate>
            Mon, 28 Jul 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG: For Biocon Pharma Limited waiver sent on 5/29/2025, answer due 7/28/2025. (Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_29260275</guid>
                <pubDate>
            Fri, 06 Jun 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG: For Biocon Pharma, Inc. waiver sent on 5/29/2025, answer due 7/28/2025. (Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_29260276</guid>
                <pubDate>
            Fri, 06 Jun 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG: For Biocon Limited waiver sent on 5/29/2025, answer due 7/28/2025. (Dellinger, Megan)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_29260277</guid>
                <pubDate>
            Fri, 06 Jun 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_29260278</guid>
                <pubDate>
            Wed, 07 May 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmf)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_29260279</guid>
                <pubDate>
            Wed, 07 May 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to Biocon Limited, Biocon Pharma Limited, and Biocon Pharma, Inc. on 4/30/2025. (Attachments: #1 Summons Issued, Biocon Pharma Limited, #2 Summons Issued, Biocon Pharma, Inc.)(jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578520</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578521</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,853,156 B2; 9,486,526 B2; 10,034,877 B2; 11,911,388 B2. (jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578522</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/18/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/18/2027. (jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578523</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578524</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT against Biocon Limited, Biocon Pharma Limited, Biocon Pharma, Inc. (Filing fee $ 405, receipt number ADEDC-4675022) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: #1 Exhibits 1-4, #2 Civil Cover Sheet)(jfm)
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_28578525</guid>
                <pubDate>
            Wed, 30 Apr 2025 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
